Cancer Causes & Control

, Volume 24, Issue 10, pp 1875–1884 | Cite as

Role of one-carbon metabolizing pathway genes and gene–nutrient interaction in the risk of non-Hodgkin lymphoma

  • Qian Li
  • Qing Lan
  • Yawei Zhang
  • Bryan A. Bassig
  • Theodore R. Holford
  • Brian Leaderer
  • Peter Boyle
  • Yong Zhu
  • Qin Qin
  • Stephen Chanock
  • Nathaniel Rothman
  • Tongzhang Zheng
Original Paper

Abstract

Purpose

Genetic polymorphisms in one-carbon metabolizing pathway genes have been associated with risk of malignant lymphoma. However, the results have been inconsistent. The objectives of this study were to examine the potential relationship between genenutrient interactions and the risk of non-Hodgkin lymphoma (NHL).

Methods

We examined 25 polymorphisms in 16 one-carbon metabolism genes for their main effect and genenutrient interactions in relation to NHL risk among 518 incident cases and 597 population-based controls of Connecticut women enrolled between 1996 and 2000.

Results

A significantly reduced risk of NHL was associated with the homozygous TT genotype in CBS (rs234706, Ex9+33C>T) (OR = 0.51, 95 % CI 0.31–0.84), the homozygous CC genotype in MBD2 (rs603097, −2176C>T) (OR = 0.37, 95 % CI 0.17–0.79), the heterozygote AG genotype in FTHFD (rs1127717, Ex21+31A>G) (OR = 0.73, 95 % CI 0.55–0.98), and a borderline significantly reduced risk of NHL was observed for the homozygous CC genotype in MTRR (rs161870, Ex5+136T>C) (OR = 0.23, 95 % CI 0.05–1.04). The reduced risk of NHL associated with these genotypes was predominately in those with higher dietary vitamin B6 and methionine intakes, as well as with higher dietary folate intake although results were less stable. A borderline significantly increased risk of NHL was also observed for CBS (rs1801181, Ex13+41C>T), FTHFD (rs2305230, Ex10−40G>T), SHMT1 (rs1979277, Ex12+138C>T), and SHMT1 (rs1979276, Ex12+236T>C), and these associations appeared to be contingent on dietary nutrient intakes.

Conclusion

Our results suggest that variation in several one-carbon metabolizing pathway genes may influence the risk of NHL through genenutrient interactions involving dietary nutrient intakes.

Keywords

Dietary nutrients Folate One-carbon metabolizing genes Non-Hodgkin lymphoma Cancer 

Supplementary material

10552_2013_264_MOESM1_ESM.docx (88 kb)
Supplementary material 1 (DOCX 88 kb)

References

  1. 1.
    Nauss KM, Newberne PM (1981) Effects of dietary folate, vitamin B12 and methionine/choline deficiency on immune function. Adv Exp Med Biol 135:63–91PubMedGoogle Scholar
  2. 2.
    Zheng T, Mayne ST, Boyle P, Holford TR, Liu WL, Flannery J (1992) Epidemiology of non-Hodgkin lymphoma in Connecticut. 1935–1988. Cancer 70:840–849PubMedCrossRefGoogle Scholar
  3. 3.
    Bassig BA, Lan Q, Rothman N, Zhang Y, Zheng T (2012) Current understanding of lifestyle and environmental factors and risk of non-Hodgkin lymphoma: an epidemiological update. J Cancer Epidemiol 2012:978930PubMedGoogle Scholar
  4. 4.
    Kuppers R (2005) Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer 5:251–262PubMedCrossRefGoogle Scholar
  5. 5.
    Rossi D, Capello D, Gloghini A et al (2004) Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia. Haematologica 89:154–164PubMedGoogle Scholar
  6. 6.
    Hanada M, Delia D, Aiello A, Stadtmauer E, Reed JC (1993) bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 82:1820–1828PubMedGoogle Scholar
  7. 7.
    Matsuo K, Suzuki R, Hamajima N et al (2001) Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphoma. Blood 97:3205–3209PubMedCrossRefGoogle Scholar
  8. 8.
    Robien K, Ulrich CM (2003) 5,10-Methylenetetrahydrofolate reductase polymorphisms and leukemia risk: a HuGE minireview. Am J Epidemiol 157:571–582PubMedCrossRefGoogle Scholar
  9. 9.
    Skibola CF, Curry JD, Nieters A (2007) Genetic susceptibility to lymphoma. Haematologica 92:960–969PubMedCrossRefGoogle Scholar
  10. 10.
    Lim U, Wang SS, Hartge P et al (2007) Gene–nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case–control study. Blood 109:3050–3059PubMedGoogle Scholar
  11. 11.
    Linnebank M, Schmidt S, Kolsch H et al (2004) The methionine synthase polymorphism D919G alters susceptibility to primary central nervous system lymphoma. Br J Cancer 90:1969–1971PubMedCrossRefGoogle Scholar
  12. 12.
    Lincz LF, Scorgie FE, Kerridge I, Potts R, Spencer A, Enno A (2003) Methionine synthase genetic polymorphism MS A2756G alters susceptibility to follicular but not diffuse large B-cell non-Hodgkin’s lymphoma or multiple myeloma. Br J Haematol 120:1051–1054PubMedCrossRefGoogle Scholar
  13. 13.
    Niclot S, Pruvot Q, Besson C et al (2006) Implication of the folate-methionine metabolism pathways in susceptibility to follicular lymphomas. Blood 108:278–285PubMedCrossRefGoogle Scholar
  14. 14.
    Hishida A, Matsuo K, Hamajima N et al (2003) Associations between polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and susceptibility to malignant lymphoma. Haematologica 88:159–166PubMedGoogle Scholar
  15. 15.
    Skibola CF, Smith MT, Hubbard A et al (2002) Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. Blood 99:3786–3791PubMedCrossRefGoogle Scholar
  16. 16.
    Lightfoot TJ, Skibola CF, Willett EV et al (2005) Risk of non-Hodgkin lymphoma associated with polymorphisms in folate-metabolizing genes. Cancer Epidemiol Biomarkers Prev 14:2999–3003PubMedCrossRefGoogle Scholar
  17. 17.
    Lee KM, Lan Q, Kricker A et al (2007) One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia. Hum Genet 122:525–533PubMedCrossRefGoogle Scholar
  18. 18.
    Skibola CF, Forrest MS, Coppede F et al (2004) Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. Blood 104:2155–2162PubMedCrossRefGoogle Scholar
  19. 19.
    Skibola CF, Smith MT, Kane E et al (1999) Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA 96:12810–12815PubMedCrossRefGoogle Scholar
  20. 20.
    Matsuo K, Hamajima N, Suzuki R et al (2004) Methylenetetrahydrofolate reductase gene (MTHFR) polymorphisms and reduced risk of malignant lymphoma. Am J Hematol 77:351–357PubMedCrossRefGoogle Scholar
  21. 21.
    Gemmati D, Ongaro A, Scapoli GL et al (2004) Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin’s lymphoma in adults. Cancer Epidemiol Biomarkers Prev 13:787–794PubMedGoogle Scholar
  22. 22.
    Chang ET, Balter KM, Torrang A et al (2006) Nutrient intake and risk of non-Hodgkin’s lymphoma. Am J Epidemiol 164:1222–1232PubMedCrossRefGoogle Scholar
  23. 23.
    Koutros S, Zhang Y, Zhu Y et al (2008) Nutrients contributing to one-carbon metabolism and risk of non-Hodgkin lymphoma subtypes. Am J Epidemiol 167:287–294PubMedCrossRefGoogle Scholar
  24. 24.
    Lim U, Schenk M, Kelemen LE et al (2005) Dietary determinants of one-carbon metabolism and the risk of non-Hodgkin’s lymphoma: NCI-SEER case–control study, 1998–2000. Am J Epidemiol 162:953–964PubMedCrossRefGoogle Scholar
  25. 25.
    Polesel J, Talamini R, Montella M et al (2006) Linoleic acid, vitamin D and other nutrient intakes in the risk of non-Hodgkin lymphoma: an Italian case–control study. Ann Oncol 17:713–718PubMedCrossRefGoogle Scholar
  26. 26.
    Zheng T, Holford TR, Leaderer B et al (2004) Diet and nutrient intakes and risk of non-Hodgkin’s lymphoma in Connecticut women. Am J Epidemiol 159:454–466PubMedCrossRefGoogle Scholar
  27. 27.
    Lan Q, Zheng T, Chanock S et al (2007) Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma. Carcinogenesis 28:823–827PubMedCrossRefGoogle Scholar
  28. 28.
    Zhang Y, Lan Q, Rothman N et al (2005) A putative exonic splicing polymorphism in the BCL6 gene and the risk of non-Hodgkin lymphoma. J Natl Cancer Inst 97:1616–1618PubMedCrossRefGoogle Scholar
  29. 29.
    Willett WC (1998) Nutritional epidemiology, 2nd edn. Oxford University Press, New YorkCrossRefGoogle Scholar
  30. 30.
    (2007) University of Minnesota Nutrition Coordinating Center. NDSR, University of Minnesota Nutrition Coordinating Center, Minneapolis, MNGoogle Scholar
  31. 31.
    Frosst P, Blom HJ, Milos R et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111–113PubMedCrossRefGoogle Scholar
  32. 32.
    van der Put NM, Gabreels F, Stevens EM et al (1998) A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 62:1044–1051PubMedCrossRefGoogle Scholar
  33. 33.
    Kawakami K, Salonga D, Park JM et al (2001) Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression. Clin Cancer Res 7:4096–4101PubMedGoogle Scholar
  34. 34.
    Lim U, Peng K, Shane B et al (2005) Polymorphisms in cytoplasmic serine hydroxymethyltransferase and methylenetetrahydrofolate reductase affect the risk of cardiovascular disease in men. J Nutr 135:1989–1994PubMedGoogle Scholar
  35. 35.
    Choi SW, Mason JB (2000) Folate and carcinogenesis: an integrated scheme. J Nutr 130:129–132PubMedGoogle Scholar
  36. 36.
    Metayer C, Scelo G, Chokkalingam AP et al (2011) Genetic variants in the folate pathway and risk of childhood acute lymphoblastic leukemia. Cancer Causes Control CCC 22:1243–1258PubMedCrossRefGoogle Scholar
  37. 37.
    Hendrich B, Abbott C, McQueen H, Chambers D, Cross S, Bird A (1999) Genomic structure and chromosomal mapping of the murine and human Mbd1, Mbd2, Mbd3, and Mbd4 genes. Mamm Genome 10:906–912PubMedCrossRefGoogle Scholar
  38. 38.
    Ng HH, Zhang Y, Hendrich B et al (1999) MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat Genet 23:58–61PubMedGoogle Scholar
  39. 39.
    Reuland SN, Vlasov AP, Krupenko SA (2006) Modular organization of FDH: exploring the basis of hydrolase catalysis. Protein Sci 15:1076–1084PubMedCrossRefGoogle Scholar
  40. 40.
    Krupenko SA, Oleinik NV (2002) 10-formyltetrahydrofolate dehydrogenase, one of the major folate enzymes, is down-regulated in tumor tissues and possesses suppressor effects on cancer cells. Cell Growth Differ 13:227–236PubMedGoogle Scholar
  41. 41.
    Krajinovic M, Lamothe S, Labuda D et al (2004) Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood 103:252–257PubMedCrossRefGoogle Scholar
  42. 42.
    Corella D, Ordovas JM (2005) Single nucleotide polymorphisms that influence lipid metabolism: interaction with dietary factors. Annu Rev Nutr 25:341–390PubMedCrossRefGoogle Scholar
  43. 43.
    Garcia-Closas M, Thompson WD, Robins JM (1998) Differential misclassification and the assessment of gene-environment interactions in case–control studies. Am J Epidemiol 147:426–433PubMedCrossRefGoogle Scholar
  44. 44.
    Garcia-Closas M, Rothman N, Lubin J (1999) Misclassification in case–control studies of gene-environment interactions: assessment of bias and sample size. Cancer Epidemiol Biomark Prev 8:1043–1050Google Scholar
  45. 45.
    Morton LM, Wang SS, Cozen W et al (2008) Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood 112:5150–5160PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Qian Li
    • 1
    • 2
  • Qing Lan
    • 3
  • Yawei Zhang
    • 1
  • Bryan A. Bassig
    • 1
  • Theodore R. Holford
    • 1
  • Brian Leaderer
    • 1
  • Peter Boyle
    • 4
  • Yong Zhu
    • 1
  • Qin Qin
    • 5
  • Stephen Chanock
    • 3
  • Nathaniel Rothman
    • 3
  • Tongzhang Zheng
    • 1
  1. 1.Department of Environmental Health SciencesYale School of Public HealthNew HavenUSA
  2. 2.Department of Preventive MedicineIcahn School of Medicine at Mount SinaiNew YorkUSA
  3. 3.Division of Cancer Epidemiology and Genetics, National Cancer InstituteNIH, DHHSBethesdaUSA
  4. 4.International Prevention Research Institute (IPRI)LyonFrance
  5. 5.Wise Laboratory of Environmental and Genetic ToxicologyUniversity of Southern MainePortlandUSA

Personalised recommendations